Literature DB >> 32785763

Letter to the editor regarding: comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis.

Boda Guo1,2, Ming Liu3,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32785763     DOI： 10.1007/s00345-020-03404-8

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  6 in total

1.  Incidence and prognostic significance of second primary cancers in renal cell carcinoma.

Authors:  Subhankar Chakraborty; Stefano R Tarantolo; Surinder K Batra; Ralph J Hauke
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

2.  Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma.

Authors:  Omar Abdel-Rahman
Journal:  Future Oncol       Date:  2017-08-24       Impact factor: 3.404

Review 3.  Chemotherapy in metastatic renal cell carcinoma today? A systematic review.

Authors:  Sebastiano Buti; Melissa Bersanelli; Angelica Sikokis; Francesca Maines; Francesco Facchinetti; Emilio Bria; Andrea Ardizzoni; Giampaolo Tortora; Francesco Massari
Journal:  Anticancer Drugs       Date:  2013-07       Impact factor: 2.248

4.  The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery.

Authors:  Giuseppe Rosiello; Alessandro Larcher; Giuseppe Fallara; Giuseppe Basile; Daniele Cignoli; Gianmarco Colandrea; Chiara Re; Francesco Trevisani; Pierre I Karakiewicz; Andrea Salonia; Roberto Bertini; Alberto Briganti; Francesco Montorsi; Umberto Capitanio
Journal:  World J Urol       Date:  2020-10-29       Impact factor: 4.226

Review 5.  The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy.

Authors:  Katrien De Wolf; Karim Vermaelen; Gert De Meerleer; Bart N Lambrecht; Piet Ost
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

6.  Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts.

Authors:  Dominick Bossé; Wanling Xie; Xun Lin; Ronit Simantov; Aly-Khan A Lalani; Jeffrey Graham; J Connor Wells; Frede Donskov; Brian Rini; Benoit Beuselinck; Ajjai Alva; Aaron Hansen; Lori Wood; Denis Soulières; Christian Kollmannsberger; Francois Patenaude; Daniel Y C Heng; Toni K Choueiri; Rana R McKay
Journal:  JCO Glob Oncol       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.